FI952859A0 - Antasidikoostumus ja sen valmistusmenetelmä - Google Patents

Antasidikoostumus ja sen valmistusmenetelmä

Info

Publication number
FI952859A0
FI952859A0 FI952859A FI952859A FI952859A0 FI 952859 A0 FI952859 A0 FI 952859A0 FI 952859 A FI952859 A FI 952859A FI 952859 A FI952859 A FI 952859A FI 952859 A0 FI952859 A0 FI 952859A0
Authority
FI
Finland
Prior art keywords
preparation
antacid composition
antacid
composition
Prior art date
Application number
FI952859A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952859A (fi
Inventor
Gary G Liversidge
Gregory L Mcintire
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of FI952859A publication Critical patent/FI952859A/fi
Publication of FI952859A0 publication Critical patent/FI952859A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI952859A 1992-12-11 1995-06-09 Antasidikoostumus ja sen valmistusmenetelmä FI952859A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98929692A 1992-12-11 1992-12-11
PCT/US1993/011720 WO1994013304A2 (en) 1992-12-11 1993-12-03 Antacid composition and method of production

Publications (2)

Publication Number Publication Date
FI952859A FI952859A (fi) 1995-06-09
FI952859A0 true FI952859A0 (fi) 1995-06-09

Family

ID=25534976

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952859A FI952859A0 (fi) 1992-12-11 1995-06-09 Antasidikoostumus ja sen valmistusmenetelmä

Country Status (10)

Country Link
EP (1) EP0673253A1 (ja)
JP (1) JPH08504442A (ja)
KR (1) KR950703982A (ja)
AU (1) AU6390894A (ja)
CA (1) CA2150383A1 (ja)
CZ (1) CZ148695A3 (ja)
FI (1) FI952859A0 (ja)
NO (1) NO952261D0 (ja)
SK (1) SK76595A3 (ja)
WO (1) WO1994013304A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714240B1 (en) * 1993-08-24 1998-09-23 Kappa Pharmaceuticals Limited Reduced absorption of fatty acids
WO1995030763A2 (en) 1994-05-09 1995-11-16 Chiron Viagene, Inc. Retroviral vectors having a reduced recombination rate
US5874112A (en) * 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
AU2002951438A0 (en) * 2002-09-17 2002-10-03 Nauveau Technology Investments Ltd Methods and compositions for treatment of excess stomach acid in mammals
RU2013148719A (ru) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата
JPWO2016104367A1 (ja) * 2014-12-22 2017-09-28 株式会社Ｌｔｔバイオファーマ 機能性ディスペプシア治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida

Also Published As

Publication number Publication date
FI952859A (fi) 1995-06-09
JPH08504442A (ja) 1996-05-14
SK76595A3 (en) 1997-01-08
NO952261L (no) 1995-06-08
CZ148695A3 (en) 1995-12-13
KR950703982A (ko) 1995-11-17
EP0673253A1 (en) 1995-09-27
AU6390894A (en) 1994-07-04
CA2150383A1 (en) 1994-06-23
WO1994013304A3 (en) 1994-09-01
WO1994013304A2 (en) 1994-06-23
NO952261D0 (no) 1995-06-08

Similar Documents

Publication Publication Date Title
FI945362A (fi) Menetelmä monosyklopentadienyyli-metallikompleksiyhdisteiden valmistamiseksi ja käyttömenetelmä
FI101310B1 (fi) Polymeerikoostumus ja menetelmä sen valmistamiseksi
FI971495A0 (fi) Vaahdonestokoostumus ja sen käyttömenetelmä
BR8803728A (pt) Composicao e metodo de revestimento
BR8901250A (pt) Composicao oral e processo de inibir calculo dental
FI891243A (fi) Hienomuotoinen piihapposooli ja menetelmä sen valmistamiseksi
FR2577139B1 (fr) Composition de vaccin et mode de sa preparation
MX9205721A (es) Metodo de uso y composiciones de win 49596-finasteride
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
KR880701694A (ko) 내화성 조성물 및 내화 피복 공법
FI942932A (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI896073A0 (fi) Kiinteä pesuainekappale ja menetelmä sen valmistamiseksi
KR880701524A (ko) 1-옥소히드로카르빌-치환 아자시클로헥산으로 되는 조성물 및 그의 용도
PT87347A (pt) Method of purifying polydextrose and composition containing same
FI945427A0 (fi) Dynemisiinianalogien enantiomeerit, niiden valmistus ja käyttö
FI952859A0 (fi) Antasidikoostumus ja sen valmistusmenetelmä
FI955123A (fi) Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi
HK48295A (en) Antimicrobial composition and method of use
AU4006989A (en) Method of inhibiting the spread of disease and infection in structures
FI955399A0 (fi) Polyolikoostumus, menetelmä sen valmistamiseksi ja sen käytöt
EP0445239A4 (en) Anti-malarial composition and method of use
FI940153A0 (fi) Palamaton komposiittirakenne ja menetelmä sen valmistamiseksi
EE9400182A (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu
FI945493A (fi) Ti (III)-pitoisen liuoksen valmistus ja sen käyttö
EE03101B1 (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NANOSYSTEMS L.L.C.

FD Application lapsed